Evidence map›Paper›PMID 24168030›Full record

ArticleBMC developmental biology2013

Differential requirement for Dab2 in the development of embryonic and extra-embryonic tissues.

Robert Moore, Kathy Qi Cai, Wensi Tao, Elizabeth R Smith, Xiang-Xi Xu

Open access · hybridAbstract read
In one paragraph

Article in BMC developmental biology, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
1.3field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 44 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Identification of the Lineage Markers and Inhibition ofInternational journal of molecular sciences · 2020
    Article
  9. Endocytic Adaptors in Cardiovascular Disease.Frontiers in cell and developmental biology · 2020
    Review
  10. Review
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Endocytosis and Physiology: Insights from Disabled-2 Deficient Mice.Frontiers in cell and developmental biology · 2016
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 1 country.

Robert Moore
Kathy Qi Cai
Wensi Tao
Elizabeth R Smith
Xiang-Xi XuDepartment of Cell Biology, University of Miami Miller School of Medicine, Miami, 33136, FL, USA. xxu2@med.miami.edu.
Sylvester Comprehensive Cancer Center · USUniversity of Miami · USFox Chase Cancer Center · US

Funding

Ovarian Cancer: Epithelial DedifferentiationR01CA079716 · NCI · UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · PI XU, XIANGXI MIKE · 1999 to 2015
$4.8M
Epithelial Positioning Organization and Ovarian CancerR01CA095071 · NCI · UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · PI XU, XIANGXI MIKE · 2002 to 2010
$3.2M
DAB2 AND RAS REGULATIONR01CA075389 · NCI · INSTITUTE FOR CANCER RESEARCH · PI XU, XIANGXI MIKE · 1997 to 2001
$534k
NCI NIH HHS R01 CA079716NCI NIH HHS R01 CA095071NCI NIH HHS R01 CA75389NCI NIH HHS R01 CA79716
6 · The paper itself

Abstract

backgroundDisabled-2 (Dab2) is an endocytic adaptor protein involved in clathrin-mediated endocytosis and cargo trafficking. Since its expression is lost in several cancer types, Dab2 has been suggested to be a tumor suppressor. In vitro studies indicate that Dab2 establishes epithelial cell polarity and organization by directing endocytic trafficking of membrane glycoproteins. Dab2 also modulates cellular signaling pathways by mediating the endocytosis and recycling of surface receptors and associated signaling components. Previously, two independent gene knockout studies have been reported, with some discrepancies in the observed embryonic phenotypes. To further clarify the in vivo roles of Dab2 in development and physiology, we designed a new floxed allele to delete dab2 gene.

resultsThe constitutive dab2 deleted embryos showed a spectrum in the degree of endoderm disorganization in E5.5 and no mutant embryos persisted at E9.5. However, the mice were grossly normal when dab2 deletion was restricted to the embryo proper and the gene was retained in extraembryonic tissues using Meox2-Cre and Sox2-Cre. Adult Dab2-deficient mice had a small but statistically significant increase in serum cholesterol levels.

conclusionThe study of the new dab2 mutant allele in embryos and embryoid bodies confirms a role for Dab2 in extraembryonic endoderm development and epithelial organization. Experimental results with embryoid bodies suggest that additional endocytic adaptors such as Arh and Numb could partially compensate for Dab2 loss. Conditional deletion indicates that Dab2 is dispensable for organ development, when the vast majority of the embryonic cells are dab2 null. However, Dab2 has a physiological role in the endocytosis of lipoproteins and cholesterol metabolism.

Indexed as

Embryonic DevelopmentAdaptor Proteins, Signal TransducingAdaptor Proteins, Vesicular TransportAnimalsApoptosis Regulatory ProteinsCells, CulturedCholesterolEmbryoid BodiesEmbryo, MammalianEmbryonic Stem CellsEndocytosisEndodermFemaleGene DeletionGenes, LethalLipoproteinsAdaptor Proteins, Signal TransducingAdaptor Proteins, Vesicular TransportApoptosis Regulatory ProteinsCholesterolDab2 protein, mouseLipoproteins

Identifiers

PMID24168030
PMCPMC3924344
OpenAlexW2082930718

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.